Safety and recommendations for vaccinations of children with inborn errors of metabolism.

Decompensation Immunodeficiency Inborn errors of metabolism Neurometabolic Urea cycle disorder Vaccination Viruses

Journal

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
ISSN: 1532-2130
Titre abrégé: Eur J Paediatr Neurol
Pays: England
ID NLM: 9715169

Informations de publication

Date de publication:
Nov 2021
Historique:
received: 12 05 2021
revised: 18 09 2021
accepted: 02 10 2021
pubmed: 22 10 2021
medline: 15 12 2021
entrez: 21 10 2021
Statut: ppublish

Résumé

Inborn errors of metabolism (IEM) are genetic disorders due to a defective metabolic pathway. The incidence of each disorder is variable and depends on the respective population. Some disorders such as urea cycle disorders (UCD) and organic acidurias, pose a high risk for a metabolic crisis culminating in a life-threatening event, especially during infections; thus, vaccines may play a crucial role in prevention. However, there are different triggers for decompensations including the notion that vaccines themselves can activate fever and malaise. Additionally, many of the IEM include immunodeficiency, placing the patients at an increased risk for infectious diseases and possibly a weaker response to immunizations. Since metabolic crises and vaccine regimens intersect in the first years of life, the question whether to vaccinate the child occupies parents and medical staff. Many metabolic experts hesitate to vaccinate IEM patients, disregarding the higher risk from the direct infections. In this paper we summarize the published data regarding the safety and recommendations for vaccinations in IEM patients, with reference to the risk for decompensations and to the immunogenic component.

Identifiants

pubmed: 34673402
pii: S1090-3798(21)00183-5
doi: 10.1016/j.ejpn.2021.10.002
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

93-99

Informations de copyright

Copyright © 2021 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors have no conflict of interest to disclose.

Auteurs

R Hady-Cohen (R)

Pediatric Neurology Unit and Magen Rare Disease Center, Wolfson Medical Center, Holon and Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

P Dragoumi (P)

1(st) Department of Pediatrics, Hippokratio General Hospital, Aristotle University, Medical School, Thessaloniki, Greece.

D Barca (D)

Pediatric Neurology Clinic, Alexandru Obregia Hospital Pediatric Neurology Discipline II, Clinical Neurosciences Department, "Carol Davila" University of Medicine, Bucharest, Romania.

B Plecko (B)

Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria.

T Lerman-Sagie (T)

Pediatric Neurology Unit and Magen Rare Disease Center, Wolfson Medical Center, Holon and Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

D Zafeiriou (D)

1(st) Department of Pediatrics, Hippokratio General Hospital, Aristotle University, Medical School, Thessaloniki, Greece. Electronic address: dizafeir@auth.gr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH